Solazyme

  • Genetically engineers microalgae in an industrial fermentation process to transform sugars into triglyceride oils
  • Operates from its three facilities: a 2,000 MT per year facility in Peoria, Illinois, a 20,000 MT per year facility in Clinton, Iowa, and a 100,000 MT per year facility in M...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

EnginZyme extends its Series A to €11 million

News Commentary | February 26, 2021

The funds will allow the company to further demonstrate the scalability of cell‑free production platforms. EnginZyme claims it has already produced catalysts at multi‑kg scales and operated pilots capable of producing 50 tons per year of product. While this is an impressive milestone, the company ... Not part of subscription

Biokemik

Company Profile | September 29, 2021

Develops routes to high‑value‑added chemical products from renewable raw materials using a combination of fermentation and catalytic processes Currently has four main bioproducts in its portfolio including acetoin, 2,3‑butanediol (2,3‑BDO), methyl ethyl ketone (MEK), and 1,3‑butadiene (1,3‑BD... To read more, click here.

Global Bioenergies

Company Profile | March 25, 2022

Uses genetically modified Escherichia coli to produce bioisobutene at a premium in gaseous form; can be used unmodified as an additive in gaseous fuel bottles or converted into isooctane, isododecane, butyl rubber, polyisobutene, methacrylic acid, or ethyl tertiary butyl ether (ETBE) Developed ... To read more, click here.